Expected Revenue Growth:
The global microtome market is expected to reach USD 585 million by 2027 from USD 425 million in 2022, at a CAGR of 6.6% during the forecast period.
microtome instruments in the product segment to witness the highest shares during the forecast period.
Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibrating Microtomes, Other Microtomes, and Microtome Accessories. The microtome instruments segment is expected to dominate the microtome market. High expenditure on microtome instruments and their essential use in the histological diagnosis of various diseases are the key factors driving the growth of the automated microtome market.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=230495411
US dominates the North American microtome market
Based on the North America region, the microtome market is devided into US and cananda. US is expected to dominate the microtome market. The high prevalence of cancer, coupled with the increasing demand for the early and effective diagnosis and treatment of cancer, is the key factor driving market growth in the US.
Key Players:
The major players in the microtome market are Danaher Corporation (US), PHC holdings corporation (Japan), Cardinal Health (US), Boeckeler Instruments, Inc (US), SM Scientific Instruments Pvt. Ltd. (India), Bright Instruments (UK), Sakura Finetek USA, Inc (US), Jinhua Yidi Medical Equipment Co., Ltd (China), Ted Pella, Inc (US), Medimeas (India), SLEE medical GmbH (Germany), Histo-Line Laboratories (Italy), microTec Laborgeräte GmbH (Germany), MEDITE Medical GmbH (Germany), Erma Inc. (Japan).
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=230495411